| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +23% |
| 3Y CAGR | +7.0% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +44% |
| 3Y CAGR | +27% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Caplin Point LaboratoriesCAPLIPOINT | ₹2,376.60 -44.80 (1.85%) | 18,414.21 | 27.16 | 5.46 | ||
PfizerPFIZER | ₹3,824.80 -32.10 (0.83%) | 17,641.24 | 20.53 | 4.2 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,565.00 +271.00 (4.31%) | 15,737.25 | 92.78 | 18.03 | ||
Natco PharmaNATCOPHARM | ₹814.60 +18.00 (2.26%) | 15,623.80 | 13.65 | 1.49 |